Phosphorylation and proteolytic cleavage of Gag proteins in budded simian immunodeficiency virus

Journal of Virology

Volumn 79, Issue 4, 2005, Pages 2484-2492

  Rue, Sarah M ^a   Roos, Jason W ^a   Tarwater, Patrick M ^b   Clements, Janice E ^a   Barber, Sheila A ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT EL PASO   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; PROTEINASE; VIRUS ENZYME; VIRUS GLYCOPROTEIN;

ARTICLE; BUDDING; DEVELOPMENTAL STAGE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIFE CYCLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIROGENESIS; VIRUS CAPSID; VIRUS INFECTIVITY;

ANIMALS; CAPSID PROTEINS; CELL LINE; GENE PRODUCTS, GAG; PHOSPHORYLATION; SIMIAN IMMUNODEFICIENCY VIRUS;

MIRIDAE; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 13444283736     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.4.2484-2492.2005     Document Type: Article

References (55)

1. Bennett, R. P., S. Rhee, R. C. Craven, E. Hunter, and J. W. Wills. 1991. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during Gag-mediated assembly. J. Virol. 65:272-280.
2. Brody, B. A., S. S. Rhee, M. A. Sommerfelt, and E. Hunter. 1992. A viral protease-mediated cleavage of the transmembrane glycoprotein of Mason-Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc. Natl. Acad. Sci. USA 89:3443-3447.
3. Bruett, L., and J. E. Clements. 2001. Functional murine leukemia virus vectors pseudotyped with the visna virus envelope show expanded visna virus cell tropism. J. Virol. 75:11464-11473.
4. Bukovsky, A. A., T. Dorfman, A. Weimann, and H. G. Gottlinger. 1997. Nef association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71:1013-1018.
5. Bukrinskaya, A. G., A. Ghorpade, N. K. Heinzinger, T. E. Smithgall, R. E. Lewis, and M. Stevenson. 1996. Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA. Proc. Natl. Acad. Sci. USA 93:367-371.
6. Burnette, B., G. Yu, and R. L. Felsted. 1993. Phosphorylation of HIV-1 Gag proteins by protein kinase C. J. Biol. Chem. 268:8698-8703.
7. Cartier, C., M. Deckert, C. Grangeasse, R. Trauger, F. Jensen, A. Bernard, A. Cozzone, C. Desgranges, and V. Boyer. 1997. Association of mitogen-activated protein kinase with human immunodeficiency virus particles. J. Virol. 71:4832-4837.
8. Cartier, C., B. Hemonnot, B. Gay, M. Bardy, C. Sanchiz, C. Devaux, and L. Briant. 2003. Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein. J. Biol. Chem. 278:35211-35219.
9. Cartier, C., P. Sivard, C. Tranchat, D. Decimo, C. Desgranges, and V. Boyer. 1999. Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection. J. Biol. Chem. 274:19434-19440.
10. di Marzo Veronese, F., T. D. Copeland, S. Oroszlan, R. C. Gallo, and M. G. Sarngadharan. 1988. Biochemical and immunological analysis of human immunodeficiency virus gag gene products p17 and p24. J. Virol. 62:795-801.
11. Freed, E. O. 1998. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 251:1-15.
12. Gallay, P., S. Swingler, C. Aiken, and D. Trono. 1995. HIV-1 infection of nondividing cells: C-terminal tyrosine phosphorylation of the viral matrix protein is a key regulator. Cell 80:379-388.
13. Gatlin, J., S. J. Arrigo, and M. G. Schmidt. 1998. HIV-1 protease regulation: the role of the major homology region and adjacent C-terminal capsid sequences. J. Biomed. Sci. 5:305-308.
14. Gatlin, J., S. J. Arrigo, and M. G. Schmidt. 1998. Regulation of intracellular human immunodeficiency virus type-1 protease activity. Virology 244:87-96.
15. Gelderblom, H. R. 1991. Assembly and morphology of HIV: potential effect of structure on viral function. AIDS 5:617-637.
16. Gelderblom, H. R., E. H. Hausmann, M. Ozel, G. Pauli, and M. A. Koch. 1987. Fine structure of human immunodeficiency virus (HIV) and immunolocalization of structural proteins. Virology 156:171-176.
17. Gelderblom, H. R., M. Ozel, and G. Pauli. 1989. Morphogenesis and morphology of HIV. Structure-function relations. Arch. Virol. 106:1-13.
18. Gottlinger, H. G., J. G. Sodroski, and W. A. Haseltine. 1989. Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 86:5781-5785.
19. Green, N., T. M. Shinnick, O. Witte, A. Ponticelli, J. G. Sutcliffe, and R. A. Lerner. 1981. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78:6023-6027.
20. Hemonnot, B., C. Cartier, B. Gay, S. Rebuffat, M. Bardy, C. Devaux, V. Boyer, and L. Briant. 2004. The host cell MAP kinase ERK-2 regulates viral assembly and release by phosphorylating the pogag protein of HIV-1. J. Biol. Chem. 279:32426-32434.
21. Mne). J. Virol. 62:2587-2595.
22. Henderson, L. E., T. D. Copeland, R. C. Sowder, A. M. Schultz, and S. Oroszlan. 1988. Analysis of proteins and peptides purified from sucrose gradient banded HTLV-III. Alan R. Liss Inc., New York, N.Y.
23. Henderson, L. E., R. Sowder, T. D. Copeland, G. Smythers, and S. Oroszlan. 1984. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 52:492-500.
24. Henderson, L. E., R. C. Sowder, T. D. Copeland, S. Oroszlan, and R. E. Benveniste. 1990. Gag precursors of HIV and SIV are cleaved into six proteins found in the mature virions. J. Med. Primatol. 19:411-419.
25. Hoglund, S., L. G. Ofverstedt, A. Nilsson, P. Lundquist, H. Gelderblom, M. Ozel, and U. Skoglund. 1992. Spatial visualization of the maturing HIV-1 core and its linkage to the envelope. AIDS Res. Hum. Retrovir. 8:1-7.
26. Hui, E. K. 2002. Virion-associated protein kinases. Cell. Mol. Life Sci. 59:920-931.
27. Jacks, T., M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331:280-283.
28. Jacque, J. M., A. Mann, H. Enslen, N. Sharova, B. Brichacek, R. J. Davis, and M. Stevenson. 1998. Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase. EMBO J. 17:2607-2618.
29. Kaplan, A. H., M. Manchester, and R. Swanstrom. 1994. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J. Virol. 68:6782-6786.
30. Kaplan, A. H., and R. Swanstrom. 1991. The HIV-1 gag precursor is processed via two pathways: implications for cytotoxicity. Biomed. Biochim. Acta 50:647-653.
31. Kaplan, A. H., and R. Swanstrom. 1991. Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc. Natl. Acad. Sci. USA 88:4528-4532.
32. Kaplan, A. H., J. A. Zack, M. Knigge, D. A. Paul, D. J. Kempf, D. W. Norbeck, and R. Swanstrom. 1993. Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J. Virol. 67:4050-4055.
33. Katsumoto, T., M. Asanaka, S. Kageyama, T. Kurimura, K. Nakajima, A. Note, H. Tanaka, and R. Sato. 1990. Budding process and maturation of human immunodeficiency virus examined by means of pre- and post-embedding immunocolloidal gold electron microscopy. J. Electron Microsc. 39:33-38.
34. Kestler, H., T. Kodama, D. Ringler, M. Marthas, N. Pedersen, A. Lackner, D. Regier, P. Sehgal, M. Daniel, N. King, et al. 1990. Induction of AIDS in rhesus monkeys by molecularly cloned simian immunodeficiency virus. Science 248:1109-1112.
35. Khan, M. A., H. Akari, S. Kao, C. Aberham, D. Davis, A. Buckler-White, and K. Strebel. 2002. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function. J. Virol. 76:9112-9123.
36. Kohl, N. E., E. A. Emini, W. A. Schleif, L. J. Davis, J. C. Heimbach, R. A. Dixon, E. M. Scolnick, and I. S. Sigal. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc. Natl. Acad. Sci. USA 85:4686-4690.
37. Kramer, R. A., M. D. Schaber, A. M. Skalka, K. Ganguly, F. Wong-Staal, and E. P. Reddy. 1986. HTLV-III gag protein is processed in yeast cells by the virus pol-protease. Science 231:1580-1584.
38. Laurent, A. G., B. Krust, M. A. Rey, L. Montagnier, and A. G. Hovanessian. 1989. Cell surface expression of several species of human immunodeficiency virus type 1 major core protein. J. Virol. 63:4074-4078.
39. Mervis, R. J., N. Ahmad, E. P. Lillehoj, M. G. Raum, F. H. R. Salazar, H. W. Chan, and S. Venkatesan. 1988. The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors. J. Virol. 62:3993-4002.
40. Muller, B., T. Patschinsky, and H. G. Krausslich. 2002. The late-domain-containing protein p6 is the predominant phosphoprotein of human immunodeficiency virus type 1 particles. J. Virol. 76:1015-1024.
41. Naso, R. B., W. L. Karshin, Y. H. Wu, and R. B. Arlinghaus. 1979. Characterization of 40,000- and 25,000-dalton intermediate precursors to Rauscher murine leukemia virus gag gene products. J. Virol. 32:187-198.
42. Palmer, E., C. Sporborg, A. Harrison, M. L. Martin, and P. Feorino. 1985. Morphology and immunoelectron microscopy of AIDS virus. Arch. Virol. 85:189-196.
43. Pandori, M. W., N. J. Fitch, H. M. Craig, D. D. Richman, C. A. Spina, and J. C. Guatelli. 1996. Producer-cell modification of human immunodeficiency virus type 1: Nef is a virion protein. J. Virol. 70:4283-4290.
44. Peng, C., B. K. Ho, T. W. Chang, and N. T. Chang. 1989. Role of human immunodeficiency virus type 1-specific protease in core protein maturation and viral infectivity. J. Virol. 63:2550-2556.
45. Pettit, S. C., M. D. Moody, R. S. Wehbie, A. H. Kaplan, P. V. Nantermet, C. A. Klein, and R. Swanstrom. 1994. The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J. Virol. 68:8017-8027.
46. Pettit, S. C., N. Sheng, R. Tritch, S. Erickson-Viitanen, and R. Swanstrom. 1998. The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv. Exp. Med. Biol. 436:15-25.
47. Regier, D. A., and R. C. Desrosiers. 1990. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. AIDS Res. Hum. Retrovir. 6:1221-1231.
48. Rittenhouse, J., M. C. Turon, R. J. Helfrich, K. S. Albrecht, D. Weigl, R. L. Simmer, F. Mordini, J. Erickson, and W. E. Kohlbrenner. 1990. Affinity purification of HIV-1 and HIV-2 proteases from recombinant E. coli strains using pepstatin-agarose. Biochem. Biophys. Res. Commun. 171:60-66.
49. Rue, S. M., J. W. Roos, L. M. Amzel, J. E. Clements, and S. A. Barber. 2003. Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication. J. Virol. 77:8009-8018.
50. Schorr, J., R. Kellner, O. Fackler, J. Freund, J. Konvalinka, N. Kienzle, H. G. Krausslich, N. Mueller-Lantzsch, and H. R. Kalbitzer. 1996. Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases. J. Virol. 70:9051-9054.
51. Theoretical Biology and Biophysics Group. 2002. HIV Sequence Compendium. Theoretical Biology and Biophysics Group, Los Alamos, N.M.
52. Tritch, R. J., Y.-S. E. Cheng, F. H. Yin, and S. Erickson-Viitanen. 1991. Mutagenesis of protease cleavage sites in the human immunodeficiency virus type 1 gag polyprotein. J. Virol. 65:922-930.
53. Vogt, V. M. 1996. Proteolytic processing and particle maturation. Curr. Top. Microbiol. Immunol. 214:95-131.
54. Welker, R., H. Kottler, H. R. Kalbitzer, and H. G. Krausslich. 1996. Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology 219:228-236.
55. Yoshinaka, Y., and R. B. Luftig. 1982. In vitro phosphorylation of murine leukemia virus proteins: specific phosphorylation of Pr65gag, the precursor of the internal core antigens. Virology 116:181-195.